Osimertinib, a specific cancer therapy, has been widely recognized to its effectiveness, which lies in the therapy of certain lung cancers.However, recent research have highlighted the possible effects of osimertinib in cardiomyopathy.This article explores the relationship between osimertinib as well as cardiomyopathy, delving into the basic mechanisms, possible dangers, as well as current research in this area.I. Mechanisms through which osimertinib may induce cardiomyopathymainly targeting the EGFR alteration in lung cancer cells, osimertinib, a tyrosine kinase blocker, has, however, raised worries about its effects on the heart.This section discusses the…
